NASDAQ:SRRK

Scholar Rock Holding Stock Insider Trading

Healthcare > Biotechnology

Buy SRRK

*Your capital is at risk

$47.30

-1.70 (-3.46%)

At Close: Jul 31, 2026

Scholar Rock Holding Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -55.60. In total, the insiders bought 3.62M and sold 3.27M SRRK shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-55.60
● Buy	3.62M shares
● Sell	3.27M shares
59% Buy Activity Moderate Positive Correlation
Sell Signal High Confidence Apr 16, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -55.6. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 16, 2025 Sell	Common Stock S-Sale	Peng Katie Director	Director	726 Value: $31.9K
Dec 16, 2025 Sell	Common Stock S-Sale	Peng Katie Director	Director	280 Value: $12.5K
Dec 12, 2025 Buy	Common Stock X-InTheMoney	Akkaraju Srinivas Director	Director	1 064 804 Value: $7.83M
Dec 12, 2025 Sell	Warrants to Purchase Common Stock X-InTheMoney	Akkaraju Srinivas Director	Director	1 064 804 Value: $7.83M
Dec 11, 2025 Buy	Common Stock X-InTheMoney	Invus Global Management, Llc 10 Percent Owner	10% Owner	1 575 008 Value: $11.6M
Dec 11, 2025 Sell	Warrant (right to buy) X-InTheMoney	Invus Global Management, Llc 10 Percent Owner	10% Owner	1 575 008 Value: $11.6M
Dec 04, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Qatanani Mo Chief Scientific Officer	Officer	65 625 Value: $1.71M
Dec 04, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Qatanani Mo Chief Scientific Officer	Officer	8 035 Value: $282.4K
Dec 04, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Qatanani Mo Chief Scientific Officer	Officer	23 571 Value: $371.2K
Dec 04, 2025 Sell	Common Stock S-Sale	Qatanani Mo Chief Scientific Officer	Officer	136 462 Value: $6.17M
Dec 04, 2025 Buy	Common Stock M-Exempt	Qatanani Mo Chief Scientific Officer	Officer	65 625 Value: $1.71M
Dec 04, 2025 Buy	Common Stock M-Exempt	Qatanani Mo Chief Scientific Officer	Officer	21 093 Value: $381.4K
Dec 04, 2025 Buy	Common Stock M-Exempt	Qatanani Mo Chief Scientific Officer	Officer	5 607 Value: $27.3K
Dec 04, 2025 Buy	Common Stock M-Exempt	Qatanani Mo Chief Scientific Officer	Officer	1 281 Value: $10K
Dec 04, 2025 Buy	Common Stock M-Exempt	Qatanani Mo Chief Scientific Officer	Officer	11 250 Value: $112.5K
Dec 04, 2025 Buy	Common Stock M-Exempt	Qatanani Mo Chief Scientific Officer	Officer	23 571 Value: $371.2K
Dec 04, 2025 Buy	Common Stock M-Exempt	Qatanani Mo Chief Scientific Officer	Officer	8 035 Value: $282.4K
Dec 04, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Qatanani Mo Chief Scientific Officer	Officer	11 250 Value: $112.5K
Dec 04, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Qatanani Mo Chief Scientific Officer	Officer	21 093 Value: $381.4K
Dec 04, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Qatanani Mo Chief Scientific Officer	Officer	1 281 Value: $10K
Dec 04, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Qatanani Mo Chief Scientific Officer	Officer	5 607 Value: $27.3K
Oct 08, 2025 Sell	Common Stock G-Gift	Hallal David Chief Executive Officer	CEO / President	205 000 Value: $0
Oct 07, 2025 Buy	Common Stock P-Purchase	Akkaraju Srinivas Director	Director	4 403 Value: $180.4K
Oct 07, 2025 Buy	Common Stock P-Purchase	Akkaraju Srinivas Director	Director	12 400 Value: $498.2K
Oct 07, 2025 Buy	Common Stock P-Purchase	Akkaraju Srinivas Director	Director	12 796 Value: $503.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SCHOLAR ROCK HOLDING CORP.

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical tria...

Read Full Profile Here